Clinical Trial Update: My Scrivener® - Measuring Effectiveness and Dose Response in Children [Phase 1, Phase 2]

View source ↗

Summary

This document reports a completed Phase 1/Phase 2 trial of My Scrivener in children, evaluating effectiveness and dose response. The study enrolled multiple neu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder
• Cerebral Palsy
• Dyslexia
• Stroke
• Traumatic Brain Injury

Drugs mentioned

• My Scrivener

Snippet

Sponsor: Obslap Research LLC | Conditions: Asperger's Syndrome, Dyslexia | Phase 1, Phase 2 | Status: COMPLETED